All Stories

  1. Comparison of structure and composition of a fossil Champsosaurus vertebra with modern Crocodylidae vertebrae: A multi-instrumental approach
  2. CD28 and CD57 define four populations with distinct phenotypic properties within human CD8 + T cells
  3. Management and Comorbidities in Middle-European Patients with Rheumatoid Arthritis: A Retrospective, Cross-sectional Comparison with COMORA Data
  4. Correction to: Nurses’ roles in the management of chronic inflammatory arthritis: a systematic review
  5. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis
  6. Clinical infrared microscopic imaging: An overview
  7. Nurses’ roles in the management of chronic inflammatory arthritis: a systematic review
  8. Validierung der deutschen Version des ASAS-Gesundheitsindex
  9. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis
  10. Tocilizumab for the treatment of giant cell arteritis
  11. Differential clinical presentation of Adamantiades-Behçet's disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study
  12. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
  13. Rheumatologie in Österreich
  14. Checklist for selecting items of electronic health records
  15. Subgrouping fibromyalgia according to prevalence data may lead to a new therapeutic concept
  16. Decline of rheumatologic care of nursing home residents with rheumatoid arthritis
  17. FRI0338 Therapeutic conformity to guidelines and drug-approval in adamantiades-behcet's disease: a retrospective analysis of a middle-european cohort
  18. Proposal for an Urgency Score as General Referral Strategy to Second- Care Rheumatology
  19. Deutsche Übersetzung und krosskulturelle Adaptation des ASAS-Gesundheitsindex
  20. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages
  21. Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults
  22. Immunsystem und rheumatische Erkrankungen im Alter
  23. Subgrouping fibromyalgia patients according to response to therapeutic interventions: a new concept for a disease with low treatment-response rates
  24. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
  25. 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
  26. Polymyalgia rheumatica: strategies for efficient practice and quality assurance
  27. Premature senescence of T-cell subsets in axial spondyloarthritis
  28. Corrigendum to “The Story of CD4+CD28−T Cells Revisited: Solved or Still Ongoing?”
  29. The Story of CD4+CD28−T Cells Revisited: Solved or Still Ongoing?
  30. Empfehlungen der Österreichische Gesellschaft für Rheumatologie und Rehabilitation/Austrian Radiology-Rheumatology Initiative for Musculoskeletal Ultrasound zur Anwendung des Ultraschalls bei rheumatischen Erkrankungen in der klinischen Praxis
  31. Häufigkeit, Diagnose und Therapie von Rezidiven bei der Polymyalgia rheumatica
  32. Klassifikationskriterien und Methoden zur Erfassung der Krankheitsaktivität bei der Polymyalgia rheumatica
  33. 5. Biomarkers in PMR, GCA and other large vessel arteritides
  34. Antiphospholipid Antibodies Predict Progression of Abdominal Aortic Aneurysms
  35. Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons
  36. Clinical implementation of musculoskeletal ultrasound in rheumatology in Austria
  37. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
  38. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica
  39. Elderly- versus younger-onset rheumatoid arthritis: Higher levels of ultrasound-detected inflammation despite comparable clinical disease activity
  40. Riesenzellarteritis
  41. Ultrasound-Defined Remission and Active Disease in Rheumatoid Arthritis: Association with Clinical and Serologic Parameters
  42. Apoptotic Effects of Antilymphocyte Globulins on Human Pro-inflammatory CD4+CD28− T-cells
  43. Patient-reported Outcomes in Polymyalgia Rheumatica
  44. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
  45. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative
  46. Erwartungen des Rheumatologen an die Bildgebung
  47. Ist es eine Polymyalgia rheumatica?
  48. Abdominal Aortic Aneurysms
  49. Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15
  50. Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly
  51. Ultrasonography in inflammatory rheumatic disease: an overview
  52. Investigation of bacterial and viral agents and immune status in Behcet’s disease patients from Iran
  53. Editorial [Hot Topic: Aging and Immune-Mediated Diseases (Guest Editors: Christian Dejaco, Christina Duftner and Michael Schirmer)]
  54. Early Aged T-Cells in Immune-Mediated Diseases
  55. Similar performance of DAS-28, CDAI, and SDAI in rheumatoid arthritis patients with and without sonographic signs of active inflammation in routine clinical practice
  56. Major vessel involvement in Behçetʼs disease: an update
  57. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus
  58. Neopterin: Marker of coronary artery disease activity, severity and/or extent in patients with clinically stable angina?
  59. Fusion of Real-time US with CT Images to Guide Sacroiliac Joint Injection in Vitro and in Vivo
  60. Problemfelder in der Schmerzmessung und Schmerztherapie im Alter
  61. Detection of vascularity in wrist tenosynovitis: power Doppler ultrasound compared to contrast-enhanced grey-scale ultrasound
  62. Rheumatologie
  63. The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project
  64. Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-α treatment response in rheumatoid arthritis
  65. 13th International Conference on Behçet’s Disease, May 24–27, 2008, Pörtschach am Wörthersee, Austria
  66. Möglichkeiten der Krankheitsaktivitätsmessung bei Vaskulitiden im klinischen Alltag
  67. Neopterin, CD4+CD28− lymphocytes and the extent and severity of coronary artery disease
  68. Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica
  69. Aktuelle Therapieansätze bei Riesenzellarteriitis
  70. An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006–2007
  71. Neue Option in der Behandlung der rheumatoiden Arthritis: Abatacept, ein selektiver Modulator der T-Zell-Kostimulation
  72. Antibodies against mutated citrullinated vimentin fail to predict anti‐TNFα treatment response in rheumatoid arthritis
  73. Polymyalgia rheumatica
  74. Empfehlungen der European League Against Rheumatism (EULAR) zur Behandlung von „Großgefäßvaskulitiden“
  75. Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients
  76. Reply
  77. Diagnose und Therapie neurologischer Manifestationen bei entzündlich-rheumatischen Erkrankungen
  78. 4 years after withdrawal of rofecoxib: where do we stand today?
  79. Biologicals in rheumatology: Austrian experiences from a rheumatic outpatient clinic
  80. Biologicals in rheumatology: Austrian experiences from a rheumatic outpatient clinic
  81. Bildgebende Verfahren in der Frühphase des Morbus Bechterew
  82. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etaner...
  83. Value of contrast-enhanced ultrasound in rheumatoid arthritis
  84. Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
  85. Use of the European preliminary criteria, the Breiman-classification tree and the American–European criteria for diagnosis of primary Sjögren’s Syndrome in daily practice: a retrospective analysis
  86. Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology
  87. Remitting seronegative syndrome with pitting edema as the presenting symptom in a young, male patient with sarcoidosis: A case report
  88. Increasing Evidence for Immune-Mediated Processes and New Therapeutic Approaches in Abdominal Aortic Aneurysms--A Review
  89. 18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: novel insight into complex pathogenesis but questionable use in predicting relapses
  90. Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases
  91. Induction of Tolerance in Autoimmune Diseases Rather Than Cure of Cancer by Interleukin-2 Therapy
  92. Kontrastmittelverstärkte Sonographie bei rheumatischen Gelenkerkrankungen
  93. Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis
  94. Sonographie synovialer und erosiver entzündlicher Veränderungen
  95. Positive and negative predictive values from published studies can be misleading for decision-making in clinical practice: reply
  96. Are regulatory T-cells linked with aging?
  97. Imbalance of regulatory T cells in human autoimmune diseases
  98. CD8 + T-Cell Subpopulations in Human Abdominal Aortic Aneurysm Lesion
  99. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—A randomized, placebo-controlled study
  100. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis?
  101. To the editor - Eur. J. Immunol. 1/2006
  102. Tryptophan degradation increases with stage in patients with rheumatoid arthritis
  103. High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis
  104. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group
  105. Reduced aortic elastic properties in a child with Takayasu arteritis: case report and literature review
  107. High Prevalence of Circulating CD4 + CD28 − T-Cells in Patients With Small Abdominal Aortic Aneurysms
  108. Inflammatory low back pain: High negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints
  109. Major vessel involvement in Beh??et disease
  110. Remitting seronegative symmetrical synovitis with pitting edema of the hands: Ultrasound, color doppler ultrasound, and magnetic resonance imaging findings
  111. Quantitative assessment of periarticular osteopenia in patients with early rheumatoid arthritis: a preliminary report
  112. Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behcet's disease-like mouse model
  113. Aktuelle diagnostische Aspekte beim asymptomatischen Bauchaortenaneurysma
  114. Venous thromboembolism in long-distance air travellers
  115. Letter to the Editor
  116. Valvular Disease and Myocardial Infarctions in a Patient With Beh??et Disease
  117. Fibromyalgia may mask onset of autoimmune diseases
  118. Lymphknotentuberkulose bei Polymyalgie-ähnlichem Syndrom: Wert der 18F-Fluorodeoxyglucose Positron Emissions Tomographie (18F-FDG-PET)
  119. 18F-Fluorodeoxyglucose-positron emission tomography: A new explorative perspective
  120. Generalized Large Vessel Arteritis Visualized by 18 Fluorodeoxyglucose-Positron Emission Tomography
  121. Splinting vs Surgery for Carpal Tunnel SyndromeSplinting vs Surgery for Carpal Tunnel Syndrome
  122. Splinting vs Surgery for Carpal Tunnel Syndrome
  123. Vascular Endothelial Growth Factor (VEGF) in Ankylosing Spondylitis - a Pilot Study
  124. The value of contrast-enhanced color doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis
  125. Clonality and Longevity of CD4+CD28null T Cells Are Associated with Defects in Apoptotic Pathways
  126. New Rearrangement Pattern after Treatment of Hairy-Cell Leukemia with 2-Chlorodeoxyadenosine
  127. Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia
  129. Severe deep white matter lesions and outcome in major depressive disorder
  130. Entamoeba hartmanni: a new causative agent in the pathogenesis of reactive arthritis?
  131. Aging-related Deficiency of CD28 Expression in CD4+ T Cells Is Associated with the Loss of Gene-specific Nuclear Factor Binding Activity
  132. Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2′,2′-difluorodeoxycytidine on human hepatoma HepG2 cells
  133. A Comparison of the Antiproliferative Properties of Recombinant Human IFN-α2 and IFN-ω in Human Bone Marrow Culture
  134. Active compression–decompression cardiopulmonary resuscitation in standing position over the patient: pros and cons of a new method
  135. The Safety Profile of Low-dose Cladribine in Refractory Rheumatoid Arthritis
  136. T Cells and Natural Killer Cells after Treatment of Hairy Cell Leukaemia with 2-Chlorodeoxyadenosine
  137. Rescuer's work capacity and duration of cardiopulmonary resuscitation
  138. Local application of antimycotics in mucormycosis cerebri: a case report.
  139. Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells
  140. Acyclovir in acute oligoarticular herpetic arthritis
  141. Minimal Residual Disease in Hairy-cell Leukemia after Treatment with 2-chlorodeoxyadenosine
  142. The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells)
  143. Fulminant hepatitis C virus infection